Form 4: Elutia Inc. Director David Colpman Acquires Stock Options
SEC Form 4 Filing
Director David Colpman acquired 31,835 stock options in Elutia Inc. on June 6, 2024, under the company's Non-Employee Director Compensation Program.
Summary
- David Colpman, a director of Elutia Inc., acquired 31,835 stock options on June 6, 2024.
- The options were granted under the Issuer's Non-Employee Director Compensation Program.
- The exercise price of the options is $3.40.
- The options vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date.
- The options expire on June 5, 2034.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively as it aligns interests. There are no indications of negative sentiment.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- The vesting schedule incentivizes continued service on the board of directors.
Industry Context
This is a standard practice for compensating non-employee directors, aligning their interests with the long-term success of the company.
Comparison to Industry Standards
- Granting stock options to directors is a common practice among publicly traded companies to incentivize performance and align interests with shareholders.
- The vesting schedule and exercise price are typical terms for such grants, often benchmarked against industry peers to ensure competitiveness.
- Companies like Medtronic and Stryker also utilize stock options as part of their director compensation packages.
Stakeholder Impact
- The granting of stock options to a director can positively impact shareholders by aligning the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of transaction: David Colpman acquired 31,835 stock options. |
| 06/05/2034 | Expiration date of the stock options. |
| 06/10/2024 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.